A biotech company uncovering the biology of cell rejuvenation, combining virtual cell models and aging clocks to find anti-aging drug targets.
Shift Bioscience / University of Cambridge
Released October 29, 2024
DNA methylation foundation model reconstructing genome-wide profiles from sparse input. Outperforms GrimAge2 aging clocks on mortality prediction.